Skip to main content
. 2014 Mar 21;6(4):276–287. doi: 10.4168/aair.2014.6.4.276

Fig. 3.

Fig. 3

The roles of serine protease and PAR-2 in AD. AMP, antimicrobial peptide; FLG, filaggrin; KLK, kallikrein; LB, lamellar body; LEKTI, lymphoepithelial Kazal-type-related inhibitor; LTN, lipoglycan; PAR-2, protease activated receptor-2; PGN, peptidoglycan; TLR, toll-like receptor; TSLP, thymic stromal lymphopoietin.